For instance, enhanced binding of Ku70 and Ku80 facilitates nonhomologous end joining (NHEJ), a predominant pathway [28] to promote DSB repair, thereby promoting oxaliplatin chemoresistance in pancreatic cancer [29]. Here, XRCC5 is linked to familial pancreatic carcinoma.